Healthcare provider profile · identity verified

Elie Osta, MD

Internal Medicine · CHARLOTTE, NC · NPI 1861468902

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	445	95
Amlodipine Besylate	Amlodipine Besylate	335	80
Metformin Hcl	Metformin Hcl	317	64
Pravastatin Sodium	Pravastatin Sodium	286	58
Lisinopril	Lisinopril	263	62
Omeprazole	Omeprazole	239	51
Duloxetine Hcl	Duloxetine Hcl	221	38
Gabapentin	Gabapentin	220	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	212	37
Metoprolol Succinate	Metoprolol Succinate	204	39
Levothyroxine Sodium	Levothyroxine Sodium	198	35
Furosemide	Furosemide	190	34
Allopurinol	Allopurinol	151	24
Metoprolol Tartrate	Metoprolol Tartrate	151	30
Fluticasone Propionate	Fluticasone Propionate	147	46
Albuterol Sulfate Hfa	Albuterol Sulfate	145	41
Simvastatin	Simvastatin	139	33
Jardiance	Empagliflozin	136	23
Glimepiride	Glimepiride	135	23
Potassium Chloride	Potassium Chloride	132	23
Losartan Potassium	Losartan Potassium	130	24
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	121	27
Chlorthalidone	Chlorthalidone	114	22
Pantoprazole Sodium	Pantoprazole Sodium	101	24
Famotidine	Famotidine	100	20
Rosuvastatin Calcium	Rosuvastatin Calcium	99	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	87	16
Eliquis	Apixaban	85	16
Ozempic	Semaglutide	85	14
Sertraline Hcl	Sertraline Hcl	75	13
Hydrochlorothiazide	Hydrochlorothiazide	70	18
Tamsulosin Hcl	Tamsulosin Hcl	69	16
Clopidogrel	Clopidogrel Bisulfate	67	13
Escitalopram Oxalate	Escitalopram Oxalate	61	suppressed
Trulicity	Dulaglutide	60	suppressed
Hydralazine Hcl	Hydralazine Hcl	59	11
Metformin Hcl Er	Metformin Hcl	59	14
Montelukast Sodium	Montelukast Sodium	56	suppressed
Tramadol Hcl	Tramadol Hcl	56	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	55	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	52	suppressed
Farxiga	Dapagliflozin Propanediol	51	12
Mirtazapine	Mirtazapine	51	suppressed
Januvia	Sitagliptin Phosphate	50	suppressed
Ondansetron Hcl	Ondansetron Hcl	50	11
Lovastatin	Lovastatin	49	12
Carvedilol	Carvedilol	48	13
Spironolactone	Spironolactone	48	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	suppressed
Nebivolol Hcl	Nebivolol Hcl	47	suppressed
Oxycodone Hcl	Oxycodone Hcl	47	suppressed
Colchicine	Colchicine	45	suppressed
Valsartan	Valsartan	45	suppressed
Linzess	Linaclotide	44	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	38	suppressed
Meloxicam	Meloxicam	36	15
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Tradjenta	Linagliptin	35	suppressed
Tresiba Flextouch U-100	Insulin Degludec	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Nifedipine Er	Nifedipine	34	suppressed
Rybelsus	Semaglutide	34	suppressed
Verapamil Er	Verapamil Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Glipizide	Glipizide	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	29	suppressed
Ketoconazole	Ketoconazole	29	14
Myrbetriq	Mirabegron	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Letrozole	Letrozole	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Finasteride	Finasteride	26	suppressed
Torsemide	Torsemide	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Baclofen	Baclofen	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Atenolol	Atenolol	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Ramelteon	Ramelteon	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Invokana	Canagliflozin	19	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Methadone Hcl	Methadone Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Celecoxib	Celecoxib	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Cefadroxil	Cefadroxil	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Febuxostat	Febuxostat	14	suppressed
Savella	Milnacipran Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	12
Acyclovir	Acyclovir	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Estradiol	Estradiol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Nystatin	Nystatin	12	suppressed
Pen Needles	Pen Needle, Diabetic	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Risperidone	Risperidone	12	suppressed
Synjardy	Empagliflozin/Metformin Hcl	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error